Page last updated: 2024-08-17

bromodeoxyuridine and Hypertension, Renal

bromodeoxyuridine has been researched along with Hypertension, Renal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dobrian, AD; Parker, SB; Prewitt, RL; Wade, SS	1

Other Studies

1 other study(ies) available for bromodeoxyuridine and Hypertension, Renal

Article	Year
AT(1) receptor inhibition does not reduce arterial wall hypertrophy or PDGF-A expression in renal hypertension. American journal of physiology. Heart and circulatory physiology, 2000, Volume: 278, Issue:2 Topics: Angiotensin Receptor Antagonists; Animals; Aorta, Thoracic; Arteries; Blood Pressure; Bromodeoxyuridine; Capillaries; Carotid Arteries; Hypertension, Renal; Hypertrophy; Losartan; Male; Mesenteric Arteries; Platelet-Derived Growth Factor; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Reference Values; RNA, Messenger	2000

Article

Year

AT(1) receptor inhibition does not reduce arterial wall hypertrophy or PDGF-A expression in renal hypertension.

American journal of physiology. Heart and circulatory physiology, 2000, Volume: 278, Issue:2

Topics: Angiotensin Receptor Antagonists; Animals; Aorta, Thoracic; Arteries; Blood Pressure; Bromodeoxyuridine; Capillaries; Carotid Arteries; Hypertension, Renal; Hypertrophy; Losartan; Male; Mesenteric Arteries; Platelet-Derived Growth Factor; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Reference Values; RNA, Messenger

2000